Treatment of hepatitis B virus-associated glomerulonephritis: A meta-analysis
Open Access
- 1 January 2010
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 16 (6), 770-7
- https://doi.org/10.3748/wjg.v16.i6.770
Abstract
AIM: To evaluate the efficacy of antiviral or corticosteroid treatment on hepatitis B virus-associated glomerulonephritis (HBV-GN). METHODS: Six and five trials were used respectively to evaluate the efficacy of either antiviral or corticosteroid treatment on HBV-GN. Pediatric patients were pooled separately to assess their response to the above treatment modalities. The primary and secondary outcomes were remission of proteinuria and clearance of Hepatitis B e-antigen (HBeAg), respectively. A fixed or random effect model was established to collect the data. RESULTS: The remission rate of proteinuria (RR = 1.69, 95% CI: 1.08-2.65) and the clearance rate of HBeAg (RR = 6.44, 95% CI: 3.11-13.35) were significantly higher in antiviral treatment group than in control group. The proteinuria remission was significantly associated with HBeAg clearance (P = 0.002). However, the difference in proteinuria remission rate was not statistically significant between corticosteroid treatment group and control group (RR = 1.45, 95% CI: 0.68-3.11). Antiviral therapy could significantly promote the HBeAg clearance in pediatric patients, but neither antiviral nor corticosteroid therapy could significantly decrease proteinuria in pediatric patients compared to controls. CONCLUSION: Antiviral but not corticosteroid treatment can decrease proteinuria and promote HBeAg clearance in HBV-GN patients.Keywords
This publication has 31 references indexed in Scilit:
- Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand.2006
- Hepatitis B Virus-Associated NephropathyAmerican Journal of Nephrology, 2004
- The effect of hepatitis B vaccination on the incidence of childhood HBV-associated nephritisPediatric Nephrology, 2003
- The Impact of the Hepatitis B Virus Vaccine on the Incidence of Hepatitis B Virus–Associated Membranous NephropathyArchives of Pediatrics & Adolescent Medicine, 2003
- HBV associated nephrotic syndrome: resolution with oral lamivudineArchives of Disease in Childhood, 2003
- Another case of HBV associated membranous glomerulonephritis resolving on lamivudineArchives of Disease in Childhood, 2003
- Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 childrenPediatric Nephrology, 2003
- Treatment of hepatitis B virus-associated nephropathy in black childrenPediatric Nephrology, 2002
- Membranous nephropathy associated with hepatitis B in Spanish children.2001
- Publication bias in meta-analysis its causes and consequencesJournal of Clinical Epidemiology, 2000